Onvansertib Product Pipeline

Pipeline

mCRPC / Abiraterone
Enrolling
mPDAC / Biomarker
Target Q1 '22
Oregon-university
CMML / Single Agent
Development
Medulloblastoma / Combo w/ radiation
Development
Ovarian / PARP inhibitors
Development
logo-dana-farber

Looking to partner with us?

Please send inquiries to bd@cardiffoncology.com